Slade completes its acquisition of the Fresenius Kabi Compounding Business
Slade completes its acquisition of the Fresenius Kabi Compounding BusinessOctober 2015 begins a new chapter at Slade. The completion of the acquisition of the Fresenius Kabi Compounding Business realizes Slade’s vision to be a truly national company providing pharmacy and TGA licensed compounding services to patients across Australia.
We welcome to Slade our new customers across Australia and our team members from Geebung (Qld), West Melbourne (Vic) and Mount Kuring-Gai (NSW). All services to customers have continued to operate smoothly as the transition occurred.For further information, please feel free to contact David Slade or Paula Clark on 03 9565 4444.